European Archives - Page 620 of 1060 - European Medical Journal

Editor's Pick: Chronic Spontaneous Urticaria: A Review of Pathological Mechanisms, Diagnosis, Clinical Management, and Treatment

Urticaria is a common mast cell-driven disease characterised by wheals and/or angioedema (), defined as chronic…

EMJ 5.1

Pulmonary Rehabilitation is Improved by In-Shoe Foot Orthosis Intervention

Pulmonary rehabilitation (PR) is currently the most cost-effective approach designed to improve exercise tolerance, peripheral muscle function…

EMJ 5.1

Epigenetics of Diabetic Nephropathy: From Biology to Therapeutics

Diabetic nephropathy (DN) is one of the major microvascular complications associated with diabetes in terms of increased healthcare costs…

EMJ 5.1

Managing Heart Disease in Pregnancy

Cardiovascular diseases complicate approximately 0.2–4.0% of pregnancies.1 Their incidence is increasing…

EMJ 5.1

Personalising Exercise and Nutrition Behaviours in Diabetes Lifestyle Prevention

The prevalence of Type 2 diabetes mellitus (T2DM) is rising globally, in some regions more than others, and overall diabetes rates are expected…

Clinical Profile of Patients with Psoriasis and their Attitude Towards the Illness

Skin diseases such as psoriasis can profoundly influence a patient’s self-image, self-esteem, and sense of wellbeing. The chronic nature of the disease…

EMJ 5.1

Attitudes and Perceptions of General Practitioners towards the National Electronic Health Record (NEHR) in Singapore

This study highlighted key demographics and perceived barriers affecting NEHR use. By raising awareness of these issues to policy makers and working to overcome these barriers, NEHR use may be increased.

EMJ 5.1

Diabetic Amyotrophy: From the Basics to the Bedside

Diabetic amyotrophy is a rare complication of diabetes compared to distal symmetric polyneuropathy, but can occasionally be encountered in clinical practice, particularly as the incidence of diabetes increases.

Talking to Claudia Martinez

GOLD sits down with Claudia Martinez, Research Programme Manager, Access to Medicine Foundation, who explains the methodology behind the Access to Medicine Foundation’s 2021 Index, why access to medicine is still a challenge for the pharmaceutical industry and how companies can adapt their processes to reach to most vulnerable patient populations.

The Digital Legacy of COVID-19

REMOTE communication tools have flourished following the rapid spread of the novel coronavirus, keeping individuals informed and united across the globe…